Articles:

Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice

A Sharma, D Glaves, CW Porter, D Raghavan, and RJ Bernacki
Clin Cancer Res 1997 3: 1239 [Abstract] [PDF]  

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study

H Hochster, L Liebes, J Speyer, J Sorich, B Taubes, R Oratz, J Wernz, A Chachoua, RH Blum, and A Zeleniuch-Jacquotte
Clin Cancer Res 1997 3: 1245 [Abstract] [PDF]  

Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies

KR Lamborn, GL DeNardo, SJ DeNardo, DS Goldstein, S Shen, EC Larkin, and LA Kroger
Clin Cancer Res 1997 3: 1253 [Abstract] [PDF]  

Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials

LP Rivory, MC Haaz, P Canal, F Lokiec, JP Armand, and J Robert
Clin Cancer Res 1997 3: 1261 [Abstract] [PDF]  

Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

KA Foon, WJ John, M Chakraborty, A Sherratt, J Garrison, M Flett, and M Bhattacharya-Chatterjee
Clin Cancer Res 1997 3: 1267 [Abstract] [PDF]  

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients

MR Albertini, JA Hank, JH Schiller, M Khorsand, AA Borchert, J Gan, R Bechhofer, B Storer, RA Reisfeld, and PM Sondel
Clin Cancer Res 1997 3: 1277 [Abstract] [PDF]  

The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer

T Miyoshi, K Kondo, N Hino, T Uyama, and Y Monden
Clin Cancer Res 1997 3: 1289 [Abstract] [PDF]  

Vitronectin binding to urokinase receptor in human breast cancer

MV Carriero, S Del Vecchio, P Franco, MI Potena, F Chiaradonna, G Botti, MP Stoppelli, and M Salvatore
Clin Cancer Res 1997 3: 1299 [Abstract] [PDF]  

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression

J Itakura, T Ishiwata, H Friess, H Fujii, Y Matsumoto, MW Buchler, and M Korc
Clin Cancer Res 1997 3: 1309 [Abstract] [PDF]  

Combination therapy with 5-fluorouracil and IFN-alpha2a induces a nonrandom increase in DNA fragments of less than 3 megabases in HT29 colon carcinoma cells

RW Horowitz, BG Heerdt, X Hu, EL Schwartz, and S Wadler
Clin Cancer Res 1997 3: 1317 [Abstract] [PDF]  

In vitro antineoplastic activity of a novel lanthionine-containing peptide

H Zheng, D Fink, H Li, X Jiang, S Aebi, P Law, M Goodman, and SB Howell
Clin Cancer Res 1997 3: 1323 [Abstract] [PDF]  

Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion

TE Hedlund, KA Moffatt, MR Uskokovic, and GJ Miller
Clin Cancer Res 1997 3: 1331 [Abstract] [PDF]  

Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents

MA Ihnat, JP Lariviere, AJ Warren, N La Ronde, JR Blaxall, KM Pierre, BW Turpie, and JW Hamilton
Clin Cancer Res 1997 3: 1339 [Abstract] [PDF]  

Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences

V Gandhi, P Huang, AJ Chapman, F Chen, and W Plunkett
Clin Cancer Res 1997 3: 1347 [Abstract] [PDF]  

Salutary clinical response of prostate cancer to antiandrogen withdrawal: assessment of flutamide in an in vitro paradigm predictive of tumor growth enhancement

LJ Brandes, GM Queen, and FS LaBella
Clin Cancer Res 1997 3: 1357 [Abstract] [PDF]  

707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma

T Takahashi, RF Irie, Y Nishinaka, and DSB Hoon
Clin Cancer Res 1997 3: 1363 [Abstract] [PDF]  

Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function

TS Bracey, AC Williams, and C Paraskeva
Clin Cancer Res 1997 3: 1371 [Abstract] [PDF]  

Functional characterization of mutant androgen receptors from androgen-independent prostate cancer

MA Fenton, TD Shuster, AM Fertig, ME Taplin, G Kolvenbag, GJ Bubley, and SP Balk
Clin Cancer Res 1997 3: 1383 [Abstract] [PDF]  

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases

AM Stapleton, TL Timme, AE Gousse, QF Li, AA Tobon, MW Kattan, KM Slawin, TM Wheeler, PT Scardino, and TC Thompson
Clin Cancer Res 1997 3: 1389 [Abstract] [PDF]  

Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis

M Furihata, Y Ohtsuki, H Sonobe, T Shuin, A Yamamoto, N Terao, and M Kuwahara
Clin Cancer Res 1997 3: 1399 [Abstract] [PDF]  

p53 alterations are associated with improved prognosis in distal colonic carcinomas

R Soong, F Grieu, P Robbins, B Dix, D Chen, R Parsons, A House, and B Iacopetta
Clin Cancer Res 1997 3: 1405 [Abstract] [PDF]  

Combined analysis of microsatellite instability and K-ras mutation increases detection incidence of normal samples from colorectal cancer patients

T Minamoto, H Esumi, A Ochiai, G Belitsky, M Mai, T Sugimura, and Z Ronai
Clin Cancer Res 1997 3: 1413 [Abstract] [PDF]  

Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome

M Filipits, RW Suchomel, S Zochbauer, R Brunner, K Lechner, and R Pirker
Clin Cancer Res 1997 3: 1419 [Abstract] [PDF]  

A prostate-specific antigen-like protein associated with renal cell carcinoma in women

J Clements, G Ward, A Kaushal, SI Hi, C Kennett, and D Nicol
Clin Cancer Res 1997 3: 1427 [Abstract] [PDF]  

Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer

CL Finstad, KO Lloyd, MG Federici, C Divgi, E Venkatraman, RR Barakat, RD Finn, SM Larson, WJ Hoskins, and JL Humm
Clin Cancer Res 1997 3: 1433 [Abstract] [PDF]  

Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family

FA Montero-Julian, H Brailly, C Sautes, I Joyeux, T Dorval, V Mosseri, K Yasukawa, J Wijdenes, A Adler, I Gorin, WH Fridman, and E Tartour
Clin Cancer Res 1997 3: 1443 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.